Qiming Venture Partners portfolio company WeRide adopts BlackBerry QNX to build ultra-safe ADAS solution

Recently, WeRide (NASDAQ: WRD), a Qiming Venture Partners portfolio company and a global leader in autonomous driving technology, announced a partnership with QNX, a subsidiary of BlackBerry Limited (hereinafter referred to as "BlackBerry"), to jointly accelerate the development and deployment of software-defined vehicle (SDV) solutions for global automotive OEMs and Tier 1 suppliers.

Under this collaboration, WeRide will deeply integrate BlackBerry QNX's advanced technology stack into WePilot, its ADAS high-level intelligent driving solution for L2++ passenger vehicles. The solution achieved mass production by the end of 2023, jointly advanced by WeRide and global top-tier Tier 1 supplier Bosch Group, and was first launched on Chery Automobile's Exeed Sterra ES and ET models, delivering an exceptional all-scenario integrated driving and parking assistance experience to end consumers.

Image | Exeed Sterra

QNX® OS for Safety is the culmination of BlackBerry's 44 years of deep expertise in embedded software systems. It has received pre-certification from top industry certification body TÜV Rheinland, fully meeting the industry's highest standards including IEC 61508 SIL 3, ISO 26262 ASIL D, and IEC 62304 Class C. Its microkernel architecture delivers industry-leading high reliability, safety, and real-time performance, making it widely adopted in safety-critical domains such as aviation, aerospace, medical, rail, and automotive.

Leveraging the QNX® OS for Safety operating system with functional safety and cybersecurity capabilities, WeRide's ADAS high-level intelligent driving solution WePilot combines defensive driving capabilities, flexible lane-changing abilities, and 360° all-round obstacle avoidance, enabling navigation-assisted driving under all conditions — all hours, all road types, and all weather. The solution is compatible with mapless technology architectures, supports multi-modal sensor configurations, and can be continuously optimized through WeRide's advanced full-stack deep learning algorithms. Its safety and reliability have been certified to multiple industry standards including ISO/SAE 21434, ISO 26262, and ASPICE CL2, helping automotive OEMs ensure exceptional quality, automotive-grade design, and functional safety.

"WeRide is committed to transforming human mobility through autonomous driving, creating a safer, more efficient, more comfortable, and more sustainable transportation environment," said Zhong Hua, Senior Vice President of WeRide. "Our partnership with QNX is a critical step toward realizing this vision. With QNX's foundational software, we are not only enhancing the performance of our driving assistance systems but also advancing autonomous vehicles as a core component of smart cities — alleviating traffic congestion, reducing carbon emissions, and improving road safety."

"WeRide continues to innovate in autonomous driving technology to drive industry transformation," said Dhiraj Handa, Senior Vice President and General Manager of QNX Asia Pacific. "We are pleased to provide them with industry-leading foundational software that ensures the highest standards of safety, reliability, and performance. With the successful mass production of the Chery Automobile Exeed Sterra ES and ET models, we believe more and more automakers will recognize the value of QNX and WeRide in creating innovative and trustworthy advanced driver assistance systems."

Past Highlights

Qiming Stars | WeRide Partners with Uber and Dubai's Roads and Transport Authority to Launch Robotaxi Service in Dubai Qiming Perspectives | Duane Kuang of Qiming Venture Partners: AI Investment in China Is Not Overheated — It Deserves Capital from Around the World Qiming Stars | Multiple Qiming Venture Partners Portfolio Companies Shine at 2025 ZGC Forum Annual Conference, Winning Multiple Awards

Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total assets under management reaching $9.5 billion. Since its inception, the firm has focused on investing in outstanding early and growth-stage companies in the Technology and Consumer (T&C) and Healthcare sectors.

To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, of which more than 210 have gone public on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through mergers and acquisitions. Over 80 portfolio companies have become recognized unicorns or super-unicorns in their respective industries.

Many Qiming Venture Partners portfolio companies have grown into the most influential companies in their fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ: BILI, 09626.HK), Zhihu (NYSE: ZH, 02390.HK), Roborock (688169.SH), UBTECH (09880.HK), WeRide (NASDAQ: WRD), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ: ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ: SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), Berry Genomics (000710.SZ), GenScript ProBio (688520.SH), Yuanxin Technology, ClinChoice, Belief BioMed, Biren Technology, and others.